CAR-T 与 CAR-NK 细胞疗法治疗卵巢癌的当前进展
Current Developments of CAR-T and CAR-NK Cell Therapies for Ovarian Cancer.
卵巢癌(OC)仍是最致命的妇科恶性肿瘤,其特征为诊断晚、肿瘤异质性和化疗耐药,导致生存率低。
44.4分
★★☆☆☆
ALL SOURCES
Current Developments of CAR-T and CAR-NK Cell Therapies for Ovarian Cancer.
卵巢癌(OC)仍是最致命的妇科恶性肿瘤,其特征为诊断晚、肿瘤异质性和化疗耐药,导致生存率低。
CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC).
(1) 背景:HNSCC 是一种高度异质且易复发的癌症。
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。